Phase 1 Study of Concurrent Sunitinib and Image-Guided Radiotherapy Followed by Maintenance Sunitinib for Patients With Oligometastases: Acute Toxicity and Preliminary Response

To determine the safety and maximum-tolerated dose of concurrent sunitinib and image-guided radiotherapy (IGRT) followed by maintenance sunitinib in oligometastastic patients. METHODS: Eligible patients had 1 to 5 sites of metastatic cancer measuring ≤6 cm. The most common treatment sites were bone,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Kao, Johnny, Packer, Stuart, Vu, Ha Linh, Schwartz, Myron E., Sung, Max W., Stock, Richard G., Lo, Yeh-Chi, Huang, Delphine, Chen, Shu-Hsia, Cesaretti, Jamie A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4370266/
https://ncbi.nlm.nih.gov/pubmed/19536893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24412
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky